1 / 7

Symposium on Pneumococcal vaccines: COI Perspectives

Symposium on Pneumococcal vaccines: COI Perspectives. Sero -epidemiology. What is new in sero -prevalence of pneumococcal serotypes in the country? Any data on prevalence of non- typable Hib disease?

milos
Download Presentation

Symposium on Pneumococcal vaccines: COI Perspectives

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Symposium on Pneumococcal vaccines: COI Perspectives

  2. Sero-epidemiology • What is new in sero-prevalence of pneumococcal serotypes in the country? • Any data on prevalence of non-typableHib disease? • What are the findings of studies/projects carried out by Wyeth & GSK on pneumo surveillance in the country? • How frequent are serotypes 3, 6A, and 19A?

  3. Efficacy of PCV 13: • Coverage according to latest Indian estimates/publication? • Indian data on efficacy/effectiveness? • Data from neighboring/developing countries? • Any new data from anywhere? • Efficacy against serotypes 3, 6A & 19A? • Any data on PMS

  4. Efficacy of PCV 10: • Coverage according to latest Indian estimates/publication? • Indian data on efficacy/effectiveness? • Data from neighboring/developing countries? • Any new data from anywhere? COMPAS studies? • Efficacy against non-typeableHib? • Any data on PMS

  5. Post-marketing surveillance: Indian perspectives • Data on PCV7 • Any provision/plan to conduct PMS on serotypes replacement

  6. Price structure of new PCVs: • How can they be made more affordable? • Any new Indian vaccine in the pipeline?

  7. Cost-effectiveness analysis • Any published data/study

More Related